MED30 Antikörper (AA 104-153)
-
- Target Alle MED30 Antikörper anzeigen
- MED30 (Mediator Complex Subunit 30 (MED30))
-
Bindungsspezifität
- AA 104-153
-
Reaktivität
- Human, Affe, Schwein
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MED30 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Human MED30
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide located between aa104-153 of human MED30 (Q96HR3, NP_542382). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Ferret, Panda, Pig (100%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product MED30 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Distilled water
- Konzentration
- Lot specific
- Buffer
- Lyophilized from PBS, 2 % sucrose.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Short term: 4°C
Long term: -20°C.
-
- Target
- MED30 (Mediator Complex Subunit 30 (MED30))
- Andere Bezeichnung
- MED30 (MED30 Produkte)
- Hintergrund
-
Name/Gene ID: MED30
Synonyms: MED30, MED30S, THRAP6, TRAP25, Mediator complex subunit 30 - Gen-ID
- 90390
- NCBI Accession
- NP_542382
- Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Nuclear Hormone Receptor Binding, Stem Cell Maintenance, Regulation of Lipid Metabolism by PPARalpha
-